Tech Company Inital Public Offerings
Devgen NV IPO
On 6/5/2005, Devgen NV completed its IPO
Transaction Overview
Company Name
Announced On
6/5/2005
Transaction Type
IPO
Amount
$36,000,000
Proceeds Purpose
The proceeds of this successful IPO will accelerate the development of products that serve a need in the crop protection and human therapeutic markets.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
Technologiepark 30
Gent, B
Belgium
Gent, B
Belgium
Phone
Website
Email Address
Overview
Devgen was founded as a technology platform company using the model organism Caenorhabditis elegans, a small nematode that is a powerful tool to unravel biological processes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thierry Bogaert
Chief Financial Officer
Wim Goemaere
VP - Human Resources
Sabine Drieghe
VP - R & D
Geert Plaetinck
Browse more venture capital transactions:
Prev: 6/3/2005: Factory Logic venture capital transaction
Next: 6/6/2005: Somaxon Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs